Switzerland· 32665057
Mydocalm mite, comprimés pelliculés
A tolperisone product containing tolperisoni hydrochloridum, registered in Switzerland by Labatec Pharma SA and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 7 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Tolperisone is registered in 7 of 19 countries.
Countries holding a registration under ATC M03BX04 (tolperisone), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 4 of them publish a price we can compare per daily dose
Tolperisone · ATC M03BX04
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Germany
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of tolperisone costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.
- Switzerland: $1.33 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Tolperisone · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.33
The record
At a glance
Swissmedic (Switzerland)- Active substance
- tolperisoni hydrochloridum
- Manufacturer
- Labatec Pharma SA
- Country
- Switzerland (CH)
- ATC code
- M03BX04
- ATC class
- Tolperisone
- Defined daily dose
- 0.2 g, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768032665057330 StkCHF 16.05
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for tolperisone.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tolperisone · interactions on record
1 record
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Tolperisone in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumTolpermyo 50 mgWill Pharma
- NetherlandsTolperison ERC 50 mg, filmomhulde tablettenEuro Registratie Collectief B.V.
- PolandMydocalmGedeon Richter Plc.
- GermanyMydocalmStrathmann Gmbh & Co. Kg
- CzechiaMYDOCALMGedeon Richter Plc., Budapešť
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Bulgaria · Мидокалм, Толкимадо
- Cyprus · Mydoflex
- Czechia · Mydocalm
- Germany · Mydocalm, Tolperison-Hcl Dura
- Hungary · Flexirizon, Meditolp
- Lithuania · Mydocalm
- Latvia · Mydocalm
- Netherlands · Tolpermyo
- Poland · Mydocalm, Mydocalm Forte
- Romania · Myderison, Mydocalm
- Slovakia · Mydocalm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ea88f08b-5ecd-4f97-818d-2bbc0b43c78e GET /v1/drugs/ea88f08b-5ecd-4f97-818d-2bbc0b43c78e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "tolperisoni hydrochloridum 50 mg",
"valid_from": "2015-09-01",
"limitations": null,
"galenic_form": "Filmtabl 50 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2015-09-01",
"self_retention_pct": 10
}See everything about tolperisone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.